MC
IART icon

Miles Capital’s Integra LifeSciences IART Stock Holding History

Miles Capital’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-8,514
Closed -$340K – 175
2016
Q2 		$340K Buy
8,514
+126
+2% +$4.53K 0.23% 96
2016
Q1 		$283K Sell
8,388
-100
-1% -$3.12K 0.19% 122
2015
Q4 		$288K Buy
+8,488
New +$265K 0.2% 126

Other funds holding IART

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Miles Capital's IART Position: Q3 2016 in Review

Miles Capital sold out of Integra LifeSciences (IART) in Q3 2016, closing a stake of 8,514 shares — an estimated $340K sold.

Miles Capital first reported a position in IART in Q4 2015 and held it in 3 quarters. The position peaked at $340K in Q2 2016. 236 funds tracked by Wall St. Rank hold IART as of Q3 2016.

  • Miles Capital reported no remaining Integra LifeSciences position as of Q3 2016 after selling out during the quarter.
  • Miles Capital sold 8,514 Integra LifeSciences shares in Q3 2016, an estimated $340K.
  • Miles Capital first reported a position in Integra LifeSciences in Q4 2015 and held it in 3 quarters.
  • Miles Capital's Integra LifeSciences position peaked at $340K in Q2 2016.
  • 236 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2016.

Based on Miles Capital's 13F filing for Q3 2016, filed 15 Nov 2016.